S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SCLX Scilex Holding Company

0.5045

0.00 (0.00%)

Pre Market

Last Updated: 20:00:24

Delayed by 15 minutes

Holding Company Shares Rally Following Board Of Directors Commentary

A U.S. pharmaceutical holding company is stealing the show so far during the mid-week session following an announcement that the company’s board of directors has authorized...

To read the full story on AllPennyStocks.com, click here.

Scilex (NASDAQ:SCLX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Scilex Charts.

Scilex (NASDAQ:SCLX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Scilex Charts.

Scilex Holding Company News

Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Tuesday 17 December 2024 (2 days ago) • GlobeNewswire Inc.

Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering
Saturday 14 December 2024 (5 days ago) • GlobeNewswire Inc.

Scilex Holding Company Announces $17 Million Registered Direct Offering
Friday 13 December 2024 (6 days ago) • GlobeNewswire Inc.

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025
Thursday 12 December 2024 (7 days ago) • GlobeNewswire Inc.

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trial
Wednesday 11 December 2024 (7 days ago) • GlobeNewswire Inc.

Scilex Holding Company Enters into a Binding Term Sheet for a Joint Venture with IPMC and Bio Open Innovation Consortium to Develop and Commercialize a Phase 2 Clinical Stage, Potential Best-In-Class Novel Oral Tablet for the Treatment of Obesity and Neuro
Tuesday 10 December 2024 (1 week ago) • GlobeNewswire Inc.

Scilex Holding Company Announces Receipt of Notice from Nasdaq
Friday 22 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
Saturday 16 November 2024 (1 month ago) • GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (L
Wednesday 30 October 2024 (2 months ago) • GlobeNewswire Inc.

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock
Tuesday 29 October 2024 (2 months ago) • GlobeNewswire Inc.

More Scilex Holding Company News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions